South and Central America Cancer Hormone Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South and Central America Cancer Hormone Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South and Central America Cancer Hormone Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South and Central America Cancer Hormone Therapy Market Regional Analysis

6.2 South and Central America Cancer Hormone Therapy Market Revenue 2021-2031 (US$ Million)

6.3 South and Central America Cancer Hormone Therapy Market Forecast Analysis

7. South and Central America Cancer Hormone Therapy Market Analysis – by Drug Class

7.1 GnRH Analogs

7.1.1 Overview
7.1.2 GnRH Analogs: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 GnRH Antagonists

7.2.1 Overview
7.2.2 GnRH Antagonists: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Androgen Receptor Antagonists

7.3.1 Overview
7.3.2 Androgen Receptor Antagonists: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Aromatase Inhibitors

7.4.1 Overview
7.4.2 Aromatase Inhibitors: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Selective Estrogen Receptor Modulators

7.5.1 Overview
7.5.2 Selective Estrogen Receptor Modulators: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Estrogen Receptor Antagonists

7.6.1 Overview
7.6.2 Estrogen Receptor Antagonists: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Thyroid Hormone Therapy

7.7.1 Overview
7.7.2 Thyroid Hormone Therapy: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Other Drug Classes

7.8.1 Overview
7.8.2 Other Drug Classes: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. South and Central America Cancer Hormone Therapy Market Analysis – by Cancer Type

8.1 Breast Cancer

8.1.1 Overview
8.1.2 Breast Cancer: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Prostate Cancer

8.2.1 Overview
8.2.2 Prostate Cancer: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Endometrial Cancer

8.3.1 Overview
8.3.2 Endometrial Cancer: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Ovarian Cancer

8.4.1 Overview
8.4.2 Ovarian Cancer: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Thyroid Cancer

8.5.1 Overview
8.5.2 Thyroid Cancer: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Other Cancer Types

8.6.1 Overview
8.6.2 Other Cancer Types: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. South and Central America Cancer Hormone Therapy Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 Injectable: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Implantable

9.3.1 Overview
9.3.2 Implantable: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. South and Central America Cancer Hormone Therapy Market Analysis – by Sales Channel

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Cancer Treatment Centers

10.2.1 Overview
10.2.2 Cancer Treatment Centers: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Specialty Clinics

10.3.1 Overview
10.3.2 Specialty Clinics: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.4 Retail Pharmacies

10.4.1 Overview
10.4.2 Retail Pharmacies: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. South and Central America Cancer Hormone Therapy Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America

11.2.1 South and Central America Cancer Hormone Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
11.2.1.1 South and Central America Cancer Hormone Therapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 Brazil: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 Brazil: South and Central America Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.1.2 Brazil: South and Central America Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.1.3 Brazil: South and Central America Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.1.4 Brazil: South and Central America Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.2 Argentina: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Argentina: South and Central America Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.2.2 Argentina: South and Central America Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.2.3 Argentina: South and Central America Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.2.4 Argentina: South and Central America Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.3 Chile: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Chile: South and Central America Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.3.2 Chile: South and Central America Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.3.3 Chile: South and Central America Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.3.4 Chile: South and Central America Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.4 Colombia: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Colombia: South and Central America Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.4.2 Colombia: South and Central America Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.4.3 Colombia: South and Central America Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.4.4 Colombia: South and Central America Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.5 Peru: South and Central America Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Peru: South and Central America Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.5.2 Peru: South and Central America Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.5.3 Peru: South and Central America Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.5.4 Peru: South and Central America Cancer Hormone Therapy Market Breakdown, by Sales Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Pfizer Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 AbbVie

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Johnson & Johnson

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Novartis AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 AstraZeneca

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Sanofi

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Eli Lilly and Co

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 F. Hoffmann-La Roche Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Astellas Pharma Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Ipsen Pharma

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

South and Central America Cancer Hormone Therapy Market (2021–2031)